Wolverine Trading
SLDB icon

Wolverine Trading’s Solid Biosciences SLDB Stock Holding History

Wolverine Trading’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-916
Closed -$33K – 6750
2021
Q3 		$33K Buy
+916
New +$38.9K ﹤0.01% 6085

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Wolverine Trading's SLDB Position: Q4 2021 in Review

Wolverine Trading sold out of Solid Biosciences (SLDB) in Q4 2021, closing a stake of 916 shares — an estimated $33K sold.

Wolverine Trading first reported a position in SLDB in Q3 2021 and held it in 1 quarter. The position peaked at $33K in Q3 2021. 82 funds tracked by Wall St. Rank hold SLDB as of Q4 2021.

  • Wolverine Trading reported no remaining Solid Biosciences position as of Q4 2021 after selling out during the quarter.
  • Wolverine Trading sold 916 Solid Biosciences shares in Q4 2021, an estimated $33K.
  • Wolverine Trading first reported a position in Solid Biosciences in Q3 2021 and held it in 1 quarter.
  • Wolverine Trading's Solid Biosciences position peaked at $33K in Q3 2021.
  • 82 funds tracked by Wall St. Rank held Solid Biosciences as of Q4 2021.

Based on Wolverine Trading's 13F filing for Q4 2021, filed 14 Feb 2022.